SYRS - Wall Street Estimates - Syros Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.1755

3.3 %

$ 4.71 M

Market Cap

-0.06

P/E

Price Target Average

6167.81%

Revenue Forecast Estimate

--44.85%

EBIT Estimate

76.53%

Net Income Estimate

24.98%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Syros Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for SYRS of $11 , with forecasts ranging from a low of $5 to a high of $15 .

SYRS Lowest Price Target Wall Street Target

5 USD 2749.00%

SYRS Average Price Target Wall Street Target

11 USD 6167.81%

SYRS Highest Price Target Wall Street Target

15 USD 8447.01%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free